We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Silencing Investor Concerns? Alnylam Achieves RNAi Milestone

News   Aug 01, 2012

 
Silencing Investor Concerns? Alnylam Achieves RNAi Milestone
 
 
 

RELATED ARTICLES

Multi-organ "Human-on-a-Chip" Enables Long-term Toxicology Testing

News

The microfluidic device with interlinking modules containing human-derived heart, liver, skeletal muscle and nervous system cells was able to maintain cellular viability and record cellular function in real-time for 28 days.

READ MORE

Two HPV Types Linked to Cervical Cancer Have Declined Since Arrival of the HPV Vaccine

News

An analysis of cervical precancers over a period of seven years showed that two strains of human papillomavirus (HPV) that have been targeted by vaccination since 2006 have declined, accounting for a smaller proportion of cervical disease, according to newly published research.

READ MORE

Salty Skin Could Shape Allergy Progression

News

A new cell culture study reveals that salt leads to the formation of Th2 cells - immune cells which are active in allergic conditions such as atopic dermatitis. The team also detected elevated salt concentrations in the skin of patients with atopic dermatitis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE